Focused Alpha’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.14M Buy
983
+577
+142% +$681K 0.28% 60
2026
Q2
$486K Sell
406
-369
-48% -$377K 0.12% 155
2026
Q1
$713K Buy
775
+102
+15% +$103K 0.22% 97
2025
Q4
$723K Buy
+673
New +$644K 0.21% 94

Other funds holding LLY

Focused Alpha's LLY Position: Q3 2026 in Review

Focused Alpha increased its Eli Lilly (LLY) stake by 142% in Q3 2026, buying an estimated $681K and bringing the position to 983 shares worth $1.14M. The position accounts for 0.28% of the portfolio, ranked #60.

Focused Alpha first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Focused Alpha held 983 shares of Eli Lilly worth $1.14M as of Q3 2026.
  • Focused Alpha bought 577 Eli Lilly shares in Q3 2026, an estimated $681K.
  • Eli Lilly made up 0.28% of Focused Alpha's portfolio in Q3 2026, its #60 holding.
  • Focused Alpha first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.